DermTech, Inc. (DMTKQ)
Market Cap | 2.45M |
Revenue (ttm) | 15.66M |
Net Income (ttm) | -89.63M |
Shares Out | 34.96M |
EPS (ttm) | -2.68 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 7,006 |
Open | 0.0662 |
Previous Close | 0.0660 |
Day's Range | 0.0662 - 0.0701 |
52-Week Range | 0.0440 - 3.7500 |
Beta | 2.42 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | n/a |
About DMTKQ
DermTech, Inc., a molecular diagnostic company, engages in the development and marketing of novel non-invasive genomics tests to aid in the diagnosis and management of melanoma in the United States. The company provides DermTech Melanoma Test (DMT), an innovative non-invasive way to enhance melanoma detection for developing product for non-melanoma skin cancers. It also offers DermTech Smart Sticker, which provides a non-invasively way to collect skin sample including standard care by using scalpel to biopsy suspicious lesions. In addition, it ... [Read more]
Financial Performance
In 2023, DermTech's revenue was $15.30 million, an increase of 5.36% compared to the previous year's $14.52 million. Losses were -$100.89 million, -13.54% less than in 2022.
Financial numbers in USD Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/4/r/press11-2484218.jpg)
DermTech Files for Voluntary Chapter 11 Protection
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary cha...
![](https://cdn.snapi.dev/images/v1/s/8/press20-2430735.jpg)
DermTech Reports First-Quarter 2024 Financial Results
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quar...
![](https://cdn.snapi.dev/images/v1/s/c/press2-2379471.jpg)
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the spec...
![](https://cdn.snapi.dev/images/v1/r/l/press5-2350723.jpg)
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that effe...
![](https://cdn.snapi.dev/images/v1/8/a/press1-2315256.jpg)
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced the presentat...
![](https://cdn.snapi.dev/images/v1/0/g/press14-2302277.jpg)
DermTech Reports Fourth-Quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its fourth-qua...
![](https://cdn.snapi.dev/images/v1/k/5/conf20-2273312.jpg)
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, will host a conference call a...
![](https://cdn.snapi.dev/images/v1/m/z/press17-2254248.jpg)
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced additional re...
![](https://cdn.snapi.dev/images/v1/j/q/press17-2234331.jpg)
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive topli...
![](https://cdn.snapi.dev/images/v1/z/6/press13-2230398.jpg)
DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that it will ...
![](https://cdn.snapi.dev/images/v1/m/b/press3-2220203.jpg)
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
SAN DIEGO--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported positive topli...
![](https://cdn.snapi.dev/images/v1/j/d/press4-2210980.jpg)
DERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DermTech, Inc. (NASDAQ: DMTK) on behalf...
![](https://cdn.snapi.dev/images/v1/i/n/press12-2198230.jpg)
DMTK DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – DMTK
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, both date...
![](https://cdn.snapi.dev/images/v1/e/a/press1-2197670.jpg)
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 15, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DermTech, Inc. ("DermTech" or...
![](https://cdn.snapi.dev/images/v1/g/w/press7-2197499.jpg)
DMTK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - DMTK
NEW YORK , Dec. 14, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2...
![](https://cdn.snapi.dev/images/v1/5/r/press14-2196681.jpg)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DermTech, Inc. (DMTK)
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of inves...
![](https://cdn.snapi.dev/images/v1/f/t/press19-2196504.jpg)
DERMTECH INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in DermTech stock or options between March 8, 2021 and November 3, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jos...
![](https://cdn.snapi.dev/images/v1/d/g/press16-2196386.jpg)
DMTK Investors Have Opportunity to Lead DermTech, Inc. Securities Fraud Lawsuit
BENSALEM, Pa. , Dec. 14, 2023 /PRNewswire/ -- Law Offices of Howard G.
![](https://cdn.snapi.dev/images/v1/7/j/press13-2195745.jpg)
FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 14, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DermTech, Inc. ("DermTech" or...
![](https://cdn.snapi.dev/images/v1/g/i/press14-2192359.jpg)
SHAREHOLDER ALERT: Levi & Korsinsky Notifies DermTech, Inc.(DMTK) Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK , Dec. 12, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK) of a class action securities lawsuit. CLASS DEFINITION:...
![](https://cdn.snapi.dev/images/v1/f/t/press16-2190620.jpg)
IMPORTANT DEADLINE REMINDER: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 11, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DermTech, Inc. ("DermTech" or...
![](https://cdn.snapi.dev/images/v1/z/q/press20-2190360.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in DermTech, Inc. of Class Action Lawsuit And Upcoming Deadline - DMTK
NEW YORK , Dec. 10, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against DermTech, Inc. ("DermTech" or the "Company") (NASDAQ: DMTK) and certain of its offic...
![](https://cdn.snapi.dev/images/v1/n/h/press9-2188791.jpg)
FINAL DEADLINE APPROACHING: The Schall Law Firm Encourages Investors in DermTech, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / December 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DermTech, Inc. ("DermTech" or ...
![](https://cdn.snapi.dev/images/v1/9/2/press19-2188656.jpg)
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action - DMTK
NEW YORK , Dec. 7, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 20...